Bicara Therapeutics Inc (BCAX)

Currency in USD
11.60
+0.11(+0.96%)
Closed·
After Hours
11.37-0.23(-1.98%)
·
BCAX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
BCAX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
11.2911.94
52 wk Range
7.8028.09
Key Statistics
Prev. Close
11.6
Open
11.64
Day's Range
11.29-11.94
52 wk Range
7.8-28.09
Volume
271.28K
Average Volume (3m)
834.31K
1-Year Change
-
Book Value / Share
8.42
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BCAX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
32.60
Upside
+181.03%
Members' Sentiments
Bearish
Bullish
ProTips
3 analysts have revised their earnings downwards for the upcoming period

Bicara Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Bicara Therapeutics Inc Company Profile

Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines a clinically validated epidermal growth factor receptor directed monoclonal antibody with a domain that binds to human transforming growth factor beta for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.

Compare BCAX to Peers and Sector

Metrics to compare
BCAX
Peers
Sector
Relationship
P/E Ratio
−6.9x−4.0x−0.5x
PEG Ratio
−0.070.000.00
Price/Book
1.4x2.1x2.6x
Price / LTM Sales
-9.7x3.3x
Upside (Analyst Target)
210.3%193.8%42.4%
Fair Value Upside
Unlock12.6%7.2%Unlock

Analyst Ratings

6 Buy
1 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 32.60
(+181.03% Upside)

Earnings

Latest Release
May 13, 2025
EPS / Forecast
-0.68 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

BCAX Income Statement

People Also Watch

54.290
ASTS
+2.26%
9.400
UMAC
+1.18%
6.01
CTNM
+15.58%
75.63
OKLO
+6.51%

FAQ

What Stock Exchange Does Bicara Therapeutics Trade On?

Bicara Therapeutics is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Bicara Therapeutics?

The stock symbol for Bicara Therapeutics is "BCAX."

What Is the Bicara Therapeutics Market Cap?

As of today, Bicara Therapeutics market cap is 626.62M.

What Is Bicara Therapeutics's Earnings Per Share (TTM)?

The Bicara Therapeutics EPS (TTM) is -3.05.

When Is the Next Bicara Therapeutics Earnings Date?

Bicara Therapeutics will release its next earnings report on 02 Sept 2025.

From a Technical Analysis Perspective, Is BCAX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Bicara Therapeutics Stock Split?

Bicara Therapeutics has split 0 times.

How Many Employees Does Bicara Therapeutics Have?

Bicara Therapeutics has 55 employees.

What is the current trading status of Bicara Therapeutics (BCAX)?

As of 31 Jul 2025, Bicara Therapeutics (BCAX) is trading at a price of 11.60, with a previous close of 11.60. The stock has fluctuated within a day range of 11.29 to 11.94, while its 52-week range spans from 7.80 to 28.09.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.